ConductScience.org, home

Paper29607136

Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.

Thompson PL and 1 other. J Thorac Dis, 2018. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial. Papers, record 29607136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29607136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Anti-inflammatory therapy with canakinumab for atherosclerotic disease: lessons from the CANTOS trial.
PubMed
Journal
J Thorac Dis
PubMed
Year
2018
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
1.64
iCite
Revised in PubMed
2020-09-30
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thompson PLPeter L
2Nidorf SMS Mark

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on28845751Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.https://conductscience.org/library/papers/28845751

Source PubMed

Download CSV of comments and corrections

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121471964Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.Clin Pharmacol Ther2011https://conductscience.org/library/papers/21471964PubMed
225917947Novel anti-inflammatory therapies for the treatment of atherosclerosis.Atherosclerosis2015https://conductscience.org/library/papers/25917947PubMed
324916606Methotrexate for treating rheumatoid arthritis.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24916606PubMed
424864079Anti-inflammatory therapies for cardiovascular disease.Eur Heart J2014https://conductscience.org/library/papers/24864079PubMed
526816301Colchicine for prevention of cardiovascular events.Cochrane Database Syst Rev2016https://conductscience.org/library/papers/26816301PubMed
623895801Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis.Am Heart J2013https://conductscience.org/library/papers/23895801PubMed
728845751Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.N Engl J Med2017https://conductscience.org/library/papers/28845751PubMed
828855077Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.Lancet2017https://conductscience.org/library/papers/28855077PubMed
923265346Low-dose colchicine for secondary prevention of cardiovascular disease.J Am Coll Cardiol2013https://conductscience.org/library/papers/23265346PubMed
1021855836Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.Am J Cardiol2011https://conductscience.org/library/papers/21855836PubMed
1129146124Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.Lancet2018https://conductscience.org/library/papers/29146124PubMed
1228844177Targeting Inflammation in Coronary Artery Disease.N Engl J Med2017https://conductscience.org/library/papers/28844177PubMed
1329055633Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.JACC Cardiovasc Imaging2018https://conductscience.org/library/papers/29055633PubMed
1428298374Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis.Ann Rheum Dis2017https://conductscience.org/library/papers/28298374PubMed
159887164Atherosclerosis--an inflammatory disease.N Engl J Med1999https://conductscience.org/library/papers/9887164PubMed
1622850787Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.Nat Rev Drug Discov2012https://conductscience.org/library/papers/22850787PubMed
1717350370Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.Am J Cardiol2007https://conductscience.org/library/papers/17350370PubMed
1825079365The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.Eur Heart J2015https://conductscience.org/library/papers/25079365PubMed
1924678955Darapladib for preventing ischemic events in stable coronary heart disease.N Engl J Med2014https://conductscience.org/library/papers/24678955PubMed
2020668705Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.PLoS One2010https://conductscience.org/library/papers/20668705PubMed

Download CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
42941917Immune Dysregulation as a Driver of Coronary Heart Disease.Int J Mol Sci2026https://conductscience.org/library/papers/42941917PubMed
42819046Inflammatory drivers of carotid atherosclerosis: signaling pathways, immune cells, and plaque stability.Front Cardiovasc Med2026https://conductscience.org/library/papers/42819046PubMed
42783044Arrhythmic Mitral Valve Prolapse as a Regional Stretch-Induced Cardiomyopathy with Fibro-Inflammatory Signature: A Conceptual Review.J Cardiovasc Dev Dis2026https://conductscience.org/library/papers/42783044PubMed
42279002Anti-Inflammatory Therapies in Acute Coronary Syndromes-A Review of Immunological, Genetic, and Clinical Challenges for Precision Medicine.J Clin Med2026https://conductscience.org/library/papers/42279002PubMed
41732594Metabolic Inflammation as a Common Thread in Cardio-Endocrine Diseases: Toward a Unified Therapeutic Framework.Cureus2026https://conductscience.org/library/papers/41732594PubMed
41595651Glial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications.Biomedicines2026https://conductscience.org/library/papers/41595651PubMed
41511355Inflammatory Mechanisms in Acute Coronary Syndromes: From Pathophysiology to Therapeutic Targets.Cells2025https://conductscience.org/library/papers/41511355PubMed
41305751Bibliometric analysis of atrial fibrillation and frailty research based on CiteSpace and VOSviewer.Medicine (Baltimore)2025https://conductscience.org/library/papers/41305751PubMed
41158407Thromboelastography and interleukin-6 predict postoperative negative remodeling of descending aorta in patients with type A aortic dissection.J Thorac Dis2025https://conductscience.org/library/papers/41158407PubMed
40699816Neuroinflammation: Mechanisms, Dual Roles, and Therapeutic Strategies in Neurological Disorders.Curr Issues Mol Biol2025https://conductscience.org/library/papers/40699816PubMed
40530726Targeting Inflammation in Type 2 Diabetes: The Role of Colchicine.Curr Diabetes Rev2026https://conductscience.org/library/papers/40530726PubMed
40488107Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation.APL Bioeng2025https://conductscience.org/library/papers/40488107PubMed
40433411Inflammasomes: novel therapeutic targets for metabolic syndrome?Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40433411PubMed
40384967Foamy macrophages in atherosclerosis: unraveling the balance between pro- and anti-inflammatory roles in disease progression.Front Cardiovasc Med2025https://conductscience.org/library/papers/40384967PubMed
40153759Predictive value of cumulative SII for MACE in STEMI patients after PCI.Medicine (Baltimore)2025https://conductscience.org/library/papers/40153759PubMed
40104140Systemic inflammation prevalence in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a population-based study using a nationwide primary care database in Spain.Front Cardiovasc Med2025https://conductscience.org/library/papers/40104140PubMed
39958615Association of systemic inflammatory response index and stroke: a cross-sectional study of NHANES, 2005-2018.Front Neurol2025https://conductscience.org/library/papers/39958615PubMed
39936945Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?Cells2025https://conductscience.org/library/papers/39936945PubMed
39465131Human and gut microbiota synergy in a metabolically active superorganism: a cardiovascular perspective.Front Cardiovasc Med2024https://conductscience.org/library/papers/39465131PubMed
39204382Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging.Pharmaceutics2024https://conductscience.org/library/papers/39204382PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29607136

GET https://conductscience.org/api/papers/v1/29607136/cited_by?page=2